F

Fennec Pharmaceuticals Inc
NASDAQ:FENC

Watchlist Manager
Fennec Pharmaceuticals Inc
NASDAQ:FENC
Watchlist
Price: 7.04 USD -1.12% Market Closed
Updated: May 18, 2024

Fennec Pharmaceuticals Inc
Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Fennec Pharmaceuticals Inc
Operating Expenses Peer Comparison

Comparables:
ABBV
GILD
AMGN
VRTX
REGN

Competitive Operating Expenses Analysis
Latest Figures & CAGR of Competitors

Company Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
F
Fennec Pharmaceuticals Inc
NASDAQ:FENC
Operating Expenses
-$32.8m
CAGR 3-Years
-22%
CAGR 5-Years
-26%
CAGR 10-Years
-33%
Abbvie Inc
NYSE:ABBV
Operating Expenses
-$20.1B
CAGR 3-Years
-1%
CAGR 5-Years
-9%
CAGR 10-Years
-9%
Gilead Sciences Inc
NASDAQ:GILD
Operating Expenses
-$12.1B
CAGR 3-Years
9%
CAGR 5-Years
-6%
CAGR 10-Years
-11%
Amgen Inc
NASDAQ:AMGN
Operating Expenses
-$12.5B
CAGR 3-Years
-7%
CAGR 5-Years
-6%
CAGR 10-Years
-3%
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
Operating Expenses
-$4.7B
CAGR 3-Years
-21%
CAGR 5-Years
-18%
CAGR 10-Years
-14%
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
Operating Expenses
-$7.3B
CAGR 3-Years
-22%
CAGR 5-Years
-15%
CAGR 10-Years
-19%

See Also

What is Fennec Pharmaceuticals Inc's Operating Expenses?
Operating Expenses
-32.8m USD

Based on the financial report for Dec 31, 2023, Fennec Pharmaceuticals Inc's Operating Expenses amounts to -32.8m USD.

What is Fennec Pharmaceuticals Inc's Operating Expenses growth rate?
Operating Expenses CAGR 10Y
-33%

Over the last year, the Operating Expenses growth was -36%. The average annual Operating Expenses growth rates for Fennec Pharmaceuticals Inc have been -22% over the past three years , -26% over the past five years , and -33% over the past ten years .